Research ArticleBioavailability and Anticonvulsant Activity of 2-Cyanoguanidinophenytoin, a Structural Analogue of Phenytoin
References and Notes (32)
Adv. Drug Delivery Rev.
(1994)- et al.
J. Pharm. Sci.
(1984) - et al.
J. Pharm. Sci.
(1983) - et al.
J. Pharm. Sci.
(1990) - et al.
Eur. J. Pharmacol.
(1985) - et al.
J. Pharm. Sci.
(1995) J. Pharm. Sci.
(1977)- et al.
Int. J. Pharm.
(1980) - et al.
J. Pharm. Sci.
(1977) - et al.
J. Pharm. Sci.
(1968)
J. Am. Med. Assoc.
(1978)
Epilepsia
(1978)
Epilepsia
(1995)
Chem. Pharm. Bull.
(1970)
Can. J. Pharm Sci.
(1970)
Arch. Pharm.
(1993)
Cited by (10)
Enhancement of oral bioavailability of phenytoin by esterification, and in vitro hydrolytic characteristics of prodrugs
1998, International Journal of PharmaceuticsSynthesis and biological evaluation of sulfonylcyanoguanidines and sulfonamidonitroethylenes as bioisosteres of hypoglycemic sulfonylureas
1997, European Journal of Medicinal ChemistrySynthesis, X-ray crystallography and antimicrobial activity of 2-cyanoguanidinophenytoin
2023, Scientific ReportsReaction of arylglyoxal hydrate derivatives with cyanoguanidine under benzilic rearrangement effect
2021, Monatshefte fur ChemieSynthesis and biological evaluation of amino acid based mutual amide prodrugs of phenytoin as anticonvulsant agents
2021, Central Nervous System Agents in Medicinal Chemistry
Copyright © 1996 Wiley-Liss, Inc., A Wiley Company. Published by Elsevier Inc. All rights reserved.